Paclitaxel-Induced Neuropathy Risk Increased in Breast Cancer With CYP2C8*3 Variant
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
CYP2C8*3 Increases Risk of Neuropathy in Breast Cancer Patients Treated With Paclitaxel
Ann. Oncol 2013 Feb 14;[EPub Ahead of Print], DL Hertz, S Roy, AA Motsinger-Reif, et alFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.